Drug maker tests new recipe for weight loss and diabetes shot
NCT ID NCT07355738
Summary
This study aims to check if a new manufacturing process for the GZR18 injection results in the same drug levels in the body as the old process. It will involve 138 healthy adult men who will receive a single dose. Researchers will measure the drug in the blood over 35 days and monitor for side effects to confirm the two versions are equivalent.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY&T2D are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Soochow University
RECRUITINGSuzhou, Suzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.